CIPLA LTD. - Updates

	< Back
13 Feb 2015
Cipla Ltd has informed BSE that a binding term sheet has been entered into with the Company's existing partner, Biopharm SPA, for establishing a joint venture ("JV") company in Algeria.<BR><BR>The JV company will manufacture and market respiratory products facilitating Ciplas front-end presence in Algeria. As per the term sheet, the Companys wholly owned subsidiary, Cipla (EU) Limited, will hold a 40% stake in the JV company while the remainder will be held by a Biopharm-led Algerian consortium. The JV company is expected to make an investment of up to USD 15 million in the construction of a manufacturing facility.<BR><BR>Cipla (EU) Limiteds initial investment in cash in the JV company is expected to be USD 6 million.<BR><BR>None of the persons belonging to Promoter / Promoter Group(s) of the Company has any interest in the transaction and it is not a related party transaction for the Company.<BR><BR>The transaction is subject to execution of definitive agreement and applicable approvals.
View all announcements for CIPLA LTD.	Source: BSE India

Stocks	Mutual Funds		Investment tracking
A-Z Gainers - Daily \| Weekly \| Monthly Losers - Daily \| Weekly \| Monthly Group-wise listing IPO \| Top IPOs Recent IPOs \| IPO News Similar Price band Most traded - By volumes Top 100 - By market capitalisation Latest Company Results Management Speaks Market News	Top 25 schemes High-risk, High-returns Medium-risk, Medium-returns Low-risk, Low-returns Gilt Funds Funds of Funds Special Funds Liquid Funds Dynamic Asset Allocation NFOs MF Selector	Equity - ELSS Equity - Index Funds Equity - Sector Funds Equity - Balance Fund Equity - Diversified Fund MF News Budget 2024	My Portfolio My Watch List If You Had Invested... Global Indicators Forex Converter Market Indices Sectoral Indices World Indices Market Astrology Advertise with us